Hebatullah A.Z.E. Abdelazim

Hebatullah A.Z.E. Abdelazim

Auto-generated profile, based on publicly available information

Hebatullah A.Z.E. Abdelazim

Otorhinolaryngology department, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2024 in Journal of Medicinal and Chemical Sciences
Verified
Other
Open access
PDF file
AAAmany I.A. Abo-Saif
Amany I.A. Abo-Saif
AHAbdulkarim Hasan
Abdulkarim Hasan
RARania R. Abdel-Maqsoud
Rania R. Abdel-Maqsoud
AIAmira N. Ismail
Amira N. Ismail
HAHebatullah A.Z.E. Abdelazim
Hebatullah A.Z.E. Abdelazim
MFMarwa Fathy
Marwa Fathy
Laryngeal cancer, particularly the squamous cell carcinoma subtype, is prevalent all over the world and is characterized by a poor prognosis and high mortality rates. Currently, no definitive prognostic markers exist for predicting the behavior of the tumor. The aim of this study is to examine the correlation between cyclin D1 and E-cadherin expression with some clinicopathological parameters in laryngeal squamous cell carcinoma (LSCC). 60 cases of LSCC were retrospectively studied concerning the clinicopathological features and the potential prognostic role of cyclin D1 and E-cadherin expression in laryngeal carcinoma, using immunohistochemical staining scores on paraffin-embedded cancer tissues from patients who were treated with surgical excision. Reduced E-cadherin expression was significantly correlated with tumor grade (p = 0.0288), T stage (p = 0.041), and lymph node metastasis (p = 0.003). Regarding Cyclin D1, a statistically significant correlation was found with lymph node metastasis (p=0.019). In contrast, cyclin D1 expression was not significantly correlated with TNM stage or tumor grade (p=0.99 and 0.66, respectively). Evaluating expression of cyclin D1 in conjunction with E-cadherin expression in laryngeal squamous cell carcinoma may prove beneficial in identifying patients with lymph node metastasis. Tumor grade, stage, and nodal metastasis can significantly affect E-cadherin expression in patients with LSCC. However, further studies using genetic testing are recommended to assess the role of E-cadherin in tumor progression.